CAV1 and breast carcinoma: To our knowledge, this is the first observation of potassium channel activation-dependent Cav1 dephosphorylation in highly metastatic breast cancer cells, which importantly, may be an effective therapeutic strategy for inhibiting migration and promoting the contact inhibition of metastatic cancers.